Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > 2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole CAS 106006-83-1

2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole CAS 106006-83-1

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 106006-83-1

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
106006-83-1 / 104617-49-4
Appearance ::
White Powder
Molecular Formula::
C7H11N3S
Molecular Weight::
169.25
EINECS NO::
600-708-5/ 600-587-9
MDL NO::
MFCD07771983
CAS NO::
106006-83-1 / 104617-49-4
Appearance ::
White Powder
Molecular Formula::
C7H11N3S
Molecular Weight::
169.25
EINECS NO::
600-708-5/ 600-587-9
MDL NO::
MFCD07771983
2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole CAS 106006-83-1

Product Description:

Product Name: 2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole CAS NO:106006-83-1

 

Synonyms:

2,6-Diamino-4,5,6,7-Tetra-Hydrobenzothiazol;

4,5,6,7-tetrahydrothieno[3,4-c]pyridine-1,3-diamine;

 

 

Chemical & Physical Properties:

Appearance : White powder.

Assay : ≥99.0%

Density: 1.31g/cm3

Melting point: >180℃

Boiling Point: 359℃ at 760 mmHg

Flash Point: 170.9±27.9℃

Refractive Index: 1.476

Vapor Pressure: 0.0±0.8 mmHg at 25℃

PSA: 93.17000

LogP: 1.82280

Solubility: Methanol (Slightly).

Category: Standards; Pharmaceutical/API Drug Impurities/Metabolites;

 

 

Safety Information:

HS Code: 2934999090

Safety Statements: S26-S36/37/39

WGK Germany :3

Risk Statements: R36/37/38

Hazard Codes: Xi

 

Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.

 

Application:

2,6-Benzothiazolediamine,4,5,6,7-tetrahydro is used to make the Parkinson's drug Pramipexole; Pramipexole intermediate;

Pramipexole is a dopamine receptor agonist that binds to the D2 subfamily of dopamine receptors with high selectivity and specificity, and has complete intrinsic activity. It has a preferential affinity for the D3 receptor among them.

 

Pramipexole relieves movement disorders in patients with Parkinson's by exciting dopamine receptors in the striatum.

 

Pramipexole is quickly and completely absorbed orally. The absolute bioavailability is higher than 90%. The maximum plasma concentration appears between 1-3 hours after taking the drug. Taking it with food will not reduce the degree of pramipexole absorption, but it will reduce its absorption rate. Pramipexole shows linear kinetic characteristics, with little difference in plasma levels between patients. Pramipexole has very low plasma protein binding (less than 20%) and a large volume of distribution (400L).

 

Our factory manufacture’s 2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole CAS 106006-83-1, mature technology, stable output, quality assurance.

Inventory Status : In Stock.

 

We can provide 4,5,6,7-Tetrahydrobenzo[d]thiazole-2,6-diamine COA (certificate of analysis),4,5,6,7-tetrahydro-2,6-benzothiazolediamine MOA (Method of Analysis), 2,6-diamino-4,5,6,7-tetrahydro-benzthiazole ROS (Route of synthesis), CAS 106006-83-1 MSDS (Material Safety Data Sheet) and other support for you !

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.